{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:02:27Z","timestamp":1790805747218,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00397426"],"award-info":[{"award-number":["RS-2024-00397426"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:56:01Z","timestamp":1776524161000},"page":"1456-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission"],"prefix":"10.1016","volume":"32","author":[{"given":"Seung Shin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-4191","authenticated-orcid":false,"given":"Yong Hwy","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1932-0234","authenticated-orcid":false,"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eprac.2026.04.010_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.010_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.010_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.eprac.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","article-title":"Approach to the patient with Prolactinoma","volume":"108","author":"Auriemma","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2026.04.010_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa652","article-title":"Predictors of the response to dopaminergic therapy in patients with Prolactinoma","volume":"105","author":"Hage","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11102-017-0820-z","article-title":"Best candidates for dopamine agonist withdrawal in patients with prolactinomas","volume":"20","author":"Ji","year":"2017","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11102-017-0806-x","article-title":"Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal","volume":"20","author":"Teixeira","year":"2017","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.010_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.010_bib10","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1210\/clinem\/dgae821","article-title":"Disease activity and maternal-fetal outcomes in pregnant women with Prolactinoma: a systematic review and meta-analysis","volume":"110","author":"Bandeira","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2-3","key":"10.1016\/j.eprac.2026.04.010_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ando.2007.03.008","article-title":"Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy","volume":"68","author":"Christin-Ma\u00eetre","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"issue":"40","key":"10.1016\/j.eprac.2026.04.010_bib12","first-page":"2117","article-title":"[Pregnancy: a way of recovering from prolactin-secreting adenoma? 18 cases]","volume":"17","author":"Bricaire","year":"1988","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.010_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(92)90094-F","article-title":"Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women","volume":"44","author":"Crosignani","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.010_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","article-title":"Prolactinoma and pregnancy: from the wish of conception to lactation","volume":"77","author":"Maiter","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"10.1016\/j.eprac.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.010_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2026.04.010_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.010_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/ijem.ijem_372_21","article-title":"Prolactinoma outcome after pregnancy and lactation: a cohort Study","volume":"25","author":"Laway","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2026.04.010_bib19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ccr3.2244","article-title":"Pregnancy-induced progressive change of prolactin-secreting macroadenoma with the development of bitemporal hemianopia and severe headache","volume":"7","author":"Sirilert","year":"2019","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2015","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.010_bib21","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-21-0462","article-title":"ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy","volume":"185","author":"Luger","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.04.010_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2265.1996.00824.x","article-title":"Long-term follow-up of patients with hyperprolactinaemia","volume":"45","author":"Jeffcoate","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fendo.2018.00768","article-title":"The mechanism and pathways of dopamine and dopamine agonists in prolactinomas","volume":"9","author":"Liu","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2026.04.010_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2265.2009.03657.x","article-title":"Factors determining the remission of microprolactinomas after dopamine agonist withdrawal","volume":"72","author":"Huda","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2026.04.010_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/a-1468-4608","article-title":"Outcomes of patients with macroprolactinoma desiring pregnancy: Follow-Up to 23 years from a single Center","volume":"53","author":"Tanrikulu","year":"2021","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.04.010_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/biomedicines13051125","article-title":"Impact of tumor size on prolactinoma characteristics and treatment outcomes: a Study of a Tunisian cohort","volume":"13","author":"Elleuch","year":"2025","journal-title":"Biomedicines"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:48:47Z","timestamp":1790804927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26009572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1530891X26009572"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.010","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}